Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abcellera Biologics Inc (NQ: ABCL )

2.730 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abcellera Biologics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
From AbCellera Biologics Inc.
Via Business Wire
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
7 Growth Stocks That Could Double Your Money in 2023
For investors that really want to roll the dice, these are the enticing growth stocks that could double your money. 
Via InvestorPlace
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript
ABCL earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Recap: AbCellera Biologics Q1 Earnings
Via Benzinga
AbCellera Reports Q1 2023 Business Results
From AbCellera Biologics Inc.
Via Business Wire
How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies
Check out these compelling opportunities. 
Via The Motley Fool
4 Analysts Have This to Say About AbCellera Biologics
Via Benzinga
Preview: AbCellera Biologics's Earnings
Via Benzinga
The Latest Analyst Ratings for AbCellera Biologics
Via Benzinga
7 Stocks Under $10 That Analysts Love
While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks. 
Via InvestorPlace
AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy
These companies are leading the way in using AI in healthcare. 
Via The Motley Fool
7 Best Stocks Under $10 to Buy in April
Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside. 
Via InvestorPlace
AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023
From AbCellera Biologics Inc.
Via Business Wire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
Via InvestorPlace
7 Stocks to Bet On if You Want to Be Richer Than Elon Musk
If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich. 
Via InvestorPlace
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023
From AbCellera Biologics Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
Via Benzinga
AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript
ABCL earnings call for the period ending December 31, 2022. 
Via The Motley Fool
AbCellera Reports Full Year 2022 Business Results
From AbCellera Biologics Inc.
Via Business Wire
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy. 
Via InvestorPlace
AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera to Report Full Year 2022 Financial Results on February 21, 2023
From AbCellera Biologics Inc.
Via Business Wire
AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent
From AbCellera Biologics Inc.
Via Business Wire
AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
From AbCellera Biologics Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.